Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy

Fig. 1

Weight and blood glucose after 16 weeks of treatment in mice. A Experimental flow chart. B Trends of body weight in mice. C Trends of blood glucose in mice. D TG: triglycerides. E TC: total cholesterol. F HDL: high-density lipoprotein cholesterol. G LDL: low-density lipoprotein cholesterol. Data were expressed as the mean ± SEM. *P < 0.05 versus CTRL; **P < 0.01 versus CTRL; #P < 0.05 versus DM; ##P < 0.01 versus DM

Back to article page